Ralph A Tripp Selected Research

Respiratory Syncytial Virus Vaccines

1/2020	Up-to-date role of biologics in the management of respiratory syncytial virus.
8/2013	Advances in and the potential of vaccines for respiratory syncytial virus.
1/2013	Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice.
12/2004	Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis.
9/2003	Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ralph A Tripp Research Topics

Disease

62	Infections 01/2022 - 07/2002
36	Human Influenza (Influenza) 01/2022 - 08/2008
31	Respiratory Syncytial Virus Infections 01/2022 - 05/2002
15	Virus Diseases (Viral Diseases) 07/2022 - 01/2003
12	Pneumonia (Pneumonitis) 01/2021 - 07/2002
5	COVID-19 01/2022 - 01/2021
5	Inflammation (Inflammations) 03/2017 - 07/2002
5	Respiratory Tract Infections (Respiratory Tract Infection) 12/2016 - 10/2013
4	Influenza in Birds (Avian Flu) 12/2017 - 01/2011
4	Poliomyelitis (Polio) 10/2017 - 01/2016
3	Orthomyxoviridae Infections 12/2021 - 05/2011
3	Weight Loss (Weight Reduction) 01/2018 - 10/2013
3	Lung Diseases (Lung Disease) 02/2015 - 09/2003
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 02/2015 - 09/2003
1	Severe Acute Respiratory Syndrome 11/2022
1	Bronchiolitis 01/2021
1	Cytokine Release Syndrome 01/2021
1	acute flaccid myelitis 10/2017
1	Osteoarthritis 11/2016
1	Stupor 08/2016

Drug/Important Bio-Agent (IBA)

29	VaccinesIBA 10/2021 - 12/2004
18	Proteins (Proteins, Gene)FDA Link 07/2022 - 09/2004
18	CytokinesIBA 12/2021 - 05/2002
15	GTP-Binding Proteins (G-Protein)IBA 07/2017 - 12/2004
14	Antiviral Agents (Antivirals)IBA 01/2022 - 02/2006
10	MicroRNAs (MicroRNA)IBA 11/2021 - 01/2012
9	AntibodiesIBA 01/2019 - 09/2003
8	Pharmaceutical PreparationsIBA 07/2022 - 01/2007
7	Hemagglutinins (Hemagglutinin)IBA 12/2020 - 10/2013
7	ChemokinesIBA 06/2012 - 01/2005
6	InterferonsIBA 12/2021 - 06/2009
6	Monoclonal AntibodiesIBA 01/2018 - 05/2009
5	Neuraminidase (Sialidase)IBA 01/2022 - 01/2011
5	EpitopesIBA 01/2022 - 09/2005
5	Respiratory Syncytial Virus VaccinesIBA 01/2020 - 09/2003
5	Glycoproteins (Glycoprotein)IBA 01/2019 - 07/2002
4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 04/2011
4	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 09/2014 - 01/2013
4	Peptides (Polypeptides)IBA 03/2014 - 07/2002
4	Substance PIBA 10/2013 - 07/2002
3	Viral ProteinsIBA 01/2022 - 01/2013
3	hypothiocyanite ion (OSCN-)IBA 01/2022 - 01/2016
3	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2004
3	Palivizumab FDA Link 01/2018 - 09/2015
3	verdinexorIBA 01/2018 - 09/2014
3	Interleukin-8 (Interleukin 8)IBA 03/2017 - 02/2007
3	EnzymesIBA 11/2016 - 01/2013
3	AntigensIBA 08/2015 - 05/2014
3	Formaldehyde (Formol)FDA Link 02/2015 - 09/2003
3	Neutralizing AntibodiesIBA 10/2013 - 08/2009
2	Probenecid (Benemid)FDA LinkGeneric 10/2021 - 01/2013
2	Indicators and Reagents (Reagents)IBA 01/2021 - 09/2004
2	Dual OxidasesIBA 01/2021 - 01/2016
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 05/2005
2	Interferon Type IIBA 01/2019 - 06/2009
2	thiocyanateIBA 01/2018 - 01/2016
2	Amino Acids FDA Link 11/2015 - 09/2005
2	MucinsIBA 09/2015 - 10/2013
2	AcidsIBA 05/2015 - 02/2007
2	Tryptophan (L-Tryptophan)FDA Link 04/2014 - 07/2013
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 05/2011 - 01/2011
2	AerosolsIBA 04/2011 - 03/2011
2	Influenza Vaccines (Influenza Vaccine)FDA Link 03/2011 - 01/2009
2	Chemokine CCL5IBA 01/2011 - 05/2002
2	Small Interfering RNA (siRNA)IBA 01/2009 - 12/2008
2	Messenger RNA (mRNA)IBA 10/2008 - 05/2002
2	InterleukinsIBA 02/2007 - 05/2002
2	Interferon-gamma (Interferon, gamma)IBA 02/2007 - 05/2002
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2022
1	Amantadine (Aman)FDA LinkGeneric 01/2022
1	nirsevimabIBA 01/2022
1	Ion Channels (Ion Channel)IBA 11/2021
1	Viral RNAIBA 01/2021
1	Losartan (Cozaar)FDA LinkGeneric 01/2021
1	CatalaseIBA 01/2021
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Transfer RNA (tRNA)IBA 01/2021
1	Clopidogrel (Plavix)FDA Link 01/2021
1	Deubiquitinating EnzymesIBA 01/2021
1	Triamterene (Dyrenium)FDA LinkGeneric 01/2021
1	selinexorIBA 01/2021
1	Small Untranslated RNAIBA 01/2021
1	Biological ProductsIBA 11/2020
1	Exportin 1 ProteinIBA 01/2018
1	IodidesIBA 01/2018
1	Synthetic Vaccines (Recombinant Vaccines)IBA 12/2017
1	bindaritIBA 03/2017
1	Ribavirin (Virazole)FDA LinkGeneric 01/2017
1	Aggrecans (Aggrecan)IBA 11/2016
1	Proteoglycans (Proteoglycan)IBA 11/2016
1	Metalloproteases (Metalloproteinases)IBA 11/2016
1	Versicans (Versican)IBA 11/2016
1	Thrombospondin 1IBA 11/2016
1	DisintegrinsIBA 11/2016
1	Attenuated VaccinesIBA 03/2016
1	Poliovirus VaccinesIBA 03/2016

Therapy/Procedure

6	Therapeutics 01/2022 - 04/2012
1	Anesthesia 08/2016